The FDA has authorized the first wearable device capable of continuously monitoring both ketone and blood sugar levels. The device enables real-time metabolic tracking for users managing diabetes and metabolic conditions.
The FDA authorization marks a significant advancement in metabolic monitoring technology. The wearable continuously measures ketone bodies and glucose levels, providing users and healthcare providers with comprehensive metabolic data.
Ketone monitoring has previously required separate testing methods, making this integration a notable development for patients following ketogenic diets or managing type 1 diabetes. The combined glucose and ketone tracking allows for more detailed insight into metabolic state.
The device represents progress in wearable health technology, following years of FDA approvals for continuous glucose monitors. This authorization suggests expanding regulatory acceptance of multi-metric wearable devices.
Details on accuracy specifications, monitoring frequency, and availability timelines were not immediately confirmed in the announcement. Healthcare providers and users managing metabolic conditions will likely be primary early adopters of the technology.
Garmin unveiled its Fenix 9 smartwatch line with OLED displays reaching 3,000 nits—twice as bright as the previous generation. The rugged timepiece starts at $999.99 for the 43mm model.
Competing humanoid robots set new speed records at the World Humanoid Robot Games, though some units caught fire during competitions. The event highlighted both advances in robotics performance and ongoing reliability challenges.
Chinese vacuum manufacturer Dreame is shutting down its automotive division after government funding ceased. Project Starry Sky, which once employed over 1,000 people, is winding down operations.